Covid “End Is In Sight”, Says WHO Chief
<!-- -->WHO Chief Tedros Adhanom Ghebreyesus. (File)Geneva, Switzerland: The number of newly reported Covid-19 cases has dropped dramatically, the World...
Year: 2022
Here are the side effects to expect from your omicron-specific Covid booster shot
If you're thinking of getting an omicron-specific Covid booster shot, you might be wondering what its side effects are —...
Aaron Rodgers on COVID and Kirk Cousins: ‘We both made it through the winter of death’
Every word that comes from an NFL quarterback's mouth is going to be placed under a microscope and analyzed, especially...
WHO: Covid Pandemic ‘Finish Line’ In Sight
ToplineThe end of the Covid-19 pandemic is “in sight,” World Health Organization Director-General Tedros Adhanom Ghebreyesus said Wednesday, while emphasizing...
COVID czar reports rise in infections, warns of fresh wave in winter
Coronavirus czar Salman Zarka said Wednesday that Israel could be facing a fresh COVID-19 wave and urged people to get...
Should you get your flu shot and COVID booster together? Here’s what experts say
A student looks back at his mother as he is vaccinated at a school-based COVID-19 vaccination clinic for students 12...
WATCH: Journalists Tout ‘Good News’ of 8.3% Inflation as Stock Market Plummets
Thank God for the media. The American people are obviously too dumb for their own good. They need professional journalists with...
/cloudfront-us-east-2.images.arcpublishing.com/reuters/T5QALPL3WZI4JDPAKY2XV24COQ.jpg "End of the COVID-19 pandemic is in sight")
End of the COVID-19 pandemic is in sight
Dr Tedros Adhanom Ghebreyesus, Director-General of the World Health Organization (WHO) speaks following his re-election during the 75th World Health...
Japan Set to Welcome Unrestricted Tourism by October
AdvertisementAfter plenty of false starts, Japan is set to fully reopen its borders to tourism next month after more than...
Rebound of COVID-19 After Treatment With Paxlovid
The recurrence of COVID-19 clinical symptoms after completing treatment is a cause for concern. Rebound COVID-19 infection after nirmatrelvir–ritonavir (Paxlovid)...